APA (7th ed.) Citation

Zhu, B., Dai, X., Liu, C., Bi, T., Liu, S., Chen, L., . . . Liu, Z. (2025). Betulinic acid as a novel AT1R inhibitor: Attenuation of liver fibrosis via modulation of endothelial–mesenchymal transition in chronic hepatic injury. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-07362-w

Chicago Style (17th ed.) Citation

Zhu, Bingwen, et al. "Betulinic Acid as a Novel AT1R Inhibitor: Attenuation of Liver Fibrosis via Modulation of Endothelial–mesenchymal Transition in Chronic Hepatic Injury." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-07362-w.

MLA (9th ed.) Citation

Zhu, Bingwen, et al. "Betulinic Acid as a Novel AT1R Inhibitor: Attenuation of Liver Fibrosis via Modulation of Endothelial–mesenchymal Transition in Chronic Hepatic Injury." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-07362-w.